Merck & Co., Inc. is 40.1x more valuable than Alkermes plc. by market capitalization ($293.16 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALKS | MRK |
|---|---|---|
| Market cap | $7.31 B | $293.16 B |
| US-listed rank | #1122 | #44 |
| Revenue (latest FY) | $1.48B | $65.01B |
| Net income (latest FY) | $241.70M | $18.25B |
| Net margin | 16.4% | 28.1% |
| P/E (trailing FY) | 30.2 | 16.1 |
| SEC filings | 1,884 | 996 |
Merck & Co., Inc. is 40.1x more valuable than Alkermes plc. by market capitalization ($293.16 B vs $7.31 B).
In their latest fiscal years, Alkermes plc. reported $1.48B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Alkermes plc. and Merck & Co., Inc., or browse the full rankings.